- Home
- GOSS vs AHG Comparison
GOSS vs AHG Comparison
Compare GOSS & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- AHG
- Stock Information
- Founded
- GOSS 2015
- AHG 2013
- Country
- GOSS United States
- AHG China
- Employees
- GOSS N/A
- AHG N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- AHG Business Services
- Sector
- GOSS Health Care
- AHG Consumer Discretionary
- Exchange
- GOSS Nasdaq
- AHG Nasdaq
- Market Cap
- GOSS 262.5M
- AHG 765.9M
- IPO Year
- GOSS 2019
- AHG N/A
- Fundamental
- Price
- GOSS $1.43
- AHG $1.66
- Analyst Decision
- GOSS Strong Buy
- AHG
- Analyst Count
- GOSS 4
- AHG 0
- Target Price
- GOSS $8.25
- AHG N/A
- AVG Volume (30 Days)
- GOSS 2.7M
- AHG 64.8K
- Earning Date
- GOSS 08-11-2025
- AHG 07-29-2025
- Dividend Yield
- GOSS N/A
- AHG N/A
- EPS Growth
- GOSS N/A
- AHG N/A
- EPS
- GOSS N/A
- AHG N/A
- Revenue
- GOSS $124,590,000.00
- AHG $8,454,946.00
- Revenue This Year
- GOSS N/A
- AHG N/A
- Revenue Next Year
- GOSS $65.50
- AHG N/A
- P/E Ratio
- GOSS N/A
- AHG N/A
- Revenue Growth
- GOSS N/A
- AHG 281.19
- 52 Week Low
- GOSS $0.66
- AHG $0.74
- 52 Week High
- GOSS $1.55
- AHG $2.35
- Technical
- Relative Strength Index (RSI)
- GOSS 65.31
- AHG 62.04
- Support Level
- GOSS $1.20
- AHG $1.07
- Resistance Level
- GOSS $1.39
- AHG $1.87
- Average True Range (ATR)
- GOSS 0.09
- AHG 0.19
- MACD
- GOSS 0.02
- AHG 0.06
- Stochastic Oscillator
- GOSS 84.06
- AHG 60.20
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.